Evaluation of Two Different CMV-Immunoglobulin Regimens for Combined CMV Prophylaxis in High-Risk Patients following Lung Transplant

Background: The clinical benefits of the common off-label use of cytomegalovirus (CMV)-specific immunoglobulin (CMV-Ig) combined with antivirals in organ transplantation have not been previously assessed. The objective was to compare the risk of CMV infection and other post-transplantation outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Mora, Víctor M., Ussetti, Piedad, de Pablo, Alicia, Iturbe, David, Laporta, Rosalía, Alonso, Rodrigo, Aguilar, Myriam, Quezada, Carlos A., Cifrián, José M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864217/
https://www.ncbi.nlm.nih.gov/pubmed/36677327
http://dx.doi.org/10.3390/microorganisms11010032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864217/
https://www.ncbi.nlm.nih.gov/pubmed/36677327
http://dx.doi.org/10.3390/microorganisms11010032

Ejemplares similares